Related Experiment Videos
Antioxidants in infection
1Department of Medicine, New England Medical Center, Boston, MA.
Journal of Nutritional Science and Vitaminology
|January 1, 1993
Summary
Antioxidants are crucial for controlling damaging oxidation in infectious diseases. Therapies boosting antioxidant levels show significant clinical benefits in managing infections and related conditions.
Area of Science:
- Biochemistry
- Immunology
- Pathophysiology
Background:
- Oxidation reactions are vital for cellular functions, including immune responses like leukocyte microbial killing.
- Uncontrolled reactive oxidative species can harm host tissues, necessitating antioxidant regulation.
- Infectious diseases involve complex oxidant-antioxidant dynamics impacting disease progression and severity.
Purpose of the Study:
- To review the role of oxidant-antioxidant systems in infectious diseases.
- To highlight specific examples of antioxidant interventions in clinical settings.
- To evaluate the therapeutic potential of enhancing antioxidant capacity in infectious disease management.
Main Methods:
- Review of literature on oxidant-antioxidant systems in host defense and infectious diseases.
- Discussion of three case examples: iron-catalyzed oxidations, nitric oxide synthase inhibition in septic shock, and glutathione replacement in HIV/AIDS.
- Analysis of data supporting the impact of antioxidant therapies on clinical outcomes.
Main Results:
- Oxidant-antioxidant balance is critical for effective host defense and preventing tissue damage during infections.
- Specific interventions targeting oxidative stress, such as superoxide scavengers and glutathione replacement, demonstrate clinical efficacy.
- Regulation of molecular iron and nitric oxide pathways are key targets for managing oxidative damage in sepsis.
Conclusions:
- Antioxidant systems play a pivotal role in combating infectious diseases.
- Therapeutic strategies aimed at increasing antioxidant potential offer a promising approach for treating various infections.
- Further research into antioxidant-based therapies could significantly improve patient outcomes in infectious disease management.